MD

Michele Dilizia

Recce Pharmaceuticals Ltd | Chief Scientific Officer, Executive Director
Ms Dilizia is a co-inventor and qualified medical scientist with a specialisation in medical microbiology and regulatory affairs. She successfully co-led the research and development of Recce's suite of anti-infective compounds, resulting in a portfolio of granted patents across the globe, including a Qualified Infectious Disease Product designation with the U.S. Food and Drug Administration (FDA).

Company and Roles

Company
Title
Tenure
Since
RCE
RCE
Recce Pharmaceuticals Ltd
  • Chief Scientific Officer
  • Executive Director
9yrs, 10mthJun 2015

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RCE
RCE
Recce Pharmaceuticals Ltd
14/11/242,828,485256,0003,100,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RCE
RCE
Recce Pharmaceuticals Ltd
14/11/24
Issued
1,600,000$0.244$390,400Issue of options
RCE
RCE
Recce Pharmaceuticals Ltd
14/12/23
Sell
836,405$0.400$334,562Off-market trade
RCE
RCE
Recce Pharmaceuticals Ltd
21/06/21
Sell
175,000$1.019$178,238On-market trade
RCE
RCE
Recce Pharmaceuticals Ltd
22/02/21
Issued
1,500,000$1.030$1,545,000Issue of options
RCE
RCE
Recce Pharmaceuticals Ltd
28/08/20
Buy
577,212$1.360$785,008Conversion of securities